Orexo AB (publ) (STO:ORX)

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
US Pharma	577.70M
US Pharma Growth	1.10%
HQ & Pipeline	61.10M
HQ & Pipeline Growth	16.16%
Digital Mental Health Programs	100.00K
Digital Mental Health Programs Growth	-75.00%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	579.90M
United States Growth	0.99%
European Union	55.00M
European Union Growth	20.61%
Rest of the World	4.00M
Rest of the World Growth	-11.11%